Early Diagnosis of Multidrug-Resistant Pneumonia Benefits Patient Outcomes
SEP 12, 2017 | CONTAGION® EDITORIAL STAFF
Alan Gross, PharmD, BCPS-AQID, Clinical Assistant Professor, Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, shares how early diagnosis of multidrug-resistant pneumonia can improve patient outcomes. With early diagnosis, health care providers can avoid using broad-spectrum antibiotics and prove a more effective targeted treatment.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
NIAID researchers make an unexpected discovery when examining how a cellular enzyme complex regulates herpesvirus; inhibiting the enzyme suppressed viral infection.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512